Health ProductsAdvisory

Jin Yu Tang Tai Han Kang Pai Pu Ling Jiao Nang; TangBaoKouFuYiDaoSuJiaoNang; Tangren 365 Kangxunpai sangge huoyisu jiaonang; Tong Ren Xiu Fu Kou Fu Yi Dao Su

· Published by Health Canada · Official notice

Details

Alert type: Advisory
Category: Drugs
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

The issue

Foreign Product Alert
2012-81
May 24, 2012
For immediate release

Health Canada is advising consumers not to use the products specified below due to concerns about possible side-effects.

Source of Alert
Hong Kong Department of Health
Product Names
Jin Yu Tang Tai Han Kang Pai Pu Ling Jiao Nang
TangBaoKouFuYiDaoSuJiaoNang
Tangren 365 Kangxunpai sangge huoyisu jiaonang
Tong Ren Xiu Fu Kou Fu Yi Dao Su

Manufacturer / Place of Origin
Unknown
Product Description
These products are promoted to control high blood sugar.

Jin Yu Tang Tai Han Kang Pai Pu Ling Jiao Nang:
TangBaoKouFuYiDaoSuJiaoNang:
Tangren 365 Kangxunpai sangge huoyisu jiaonang:
Tong Ren Xiu Fu Kou Fu Yi Dao Su:
Reason for Warning
The Hong Kong Department of Health (DH) warned consumers not to use these products after they were found to contain undeclared pharmaceutical ingredients as follows:
Product Undeclared Ingredient
Jin Yu Tang Tai Han Kang Pai Pu Ling Jiao Nang metformin
glibenclamide
rosiglitazone
phenolphthalein
TangBaoKouFuYiDaoSuJiaoNang metformin
glibenclamide
phenformin
Tangren 365 Kangxunpai sangge huoyisu jiaonang glimepiride
rosiglitazone
phenformin
hydrochlorothiazide
Tong Ren Xiu Fu Kou Fu Yi Dao Su glibenclamide phenformin
Metformin, glibenclamide (also known as glyburide), glimepiride and rosiglitazone are prescription drugs used to control high blood sugar in patients with Type 2 diabetes. These drugs should only be taken under the supervision of a healthcare practitioner. Phenformin was previously used for the treatment of Type 2 diabetes but is no longer authorized for sale in Canada because of its association with a life threatening risk of lactic acidosis, an often fatal metabolic disorder in which an abnormal amount of lactic acid accumulates in the blood. Phenolphthalein was previously used as a laxative but is no longer authorized for sale in Canada because it may cause cancer. Hydrochlorothiazide is a prescription diuretic used to remove excess fluid from the body. It should only be taken under the supervision of a health care practitioner. According to the Hong Kong Department of Health (DH) press releases: Jin Yu Tang Tai Han Kang Pai Pu Ling Jiao Nang was investigated by the DH after a local hospital authority reported the suspicious product. TangBaoKouFuYiDaoSuJiaoNang was investigated by the DH after a local hospital authority reported a 69-year-old diabetic man had been admitted to a Hong Kong hospital because of dizziness, nausea and vomiting. In addition to taking prescribed diabetes medication, he had been self-medicating with this product for about three months. He was suffering from hypoglycemia (low blood sugar) and renal (kidney) failure. The patient was treated and discharged. Tangren 365 Kangxunpai sangge huoyisu jiaonang was investigated by the DH after a local hospital authority reported a 67-year-old diabetic man had been admitted to a Hong Kong hospital because of dizziness and chest discomfort. The patient claimed he had been using this product for his diabetes for about two years, and had purchased the product at a drug store in Kunming, Yunnan Province. He was later discharged. Tong Ren Xiu Fu Kou Fu Yi Dao Su was investigated by the DH after a local hospital authority reported an 82-year-old female patient had been admitted to a Hong Kong hospital because she appeared “dull-looking.” She was found to have low blood glucose (sugar) and a drug-related reaction was suspected. She was later discharged. The product had been purchased in Mainland China.
Possible Side-Effects
Side-effects associated with metformin, glibenclamide, glimepiride, rosiglitazone and phenformin include low blood sugar, which may cause sweating, paleness, chills, dizziness, headache, dizziness and confusion. Rosiglitazone can also cause fluid retention and cardiovascular side effects such as heart failure and chest pain. In addition to the risk of cancer, side-effects associated with phenolphthalein include decreased blood pressure skin rash and gastrointestinal bleeding. Side effects association with hydrochlorothiazide include muscle cramps, dizziness, low blood pressure, headache and nausea.

Media enquiries

Health Canada
(613) 957-2983
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime